CI · sample dossier
The Cigna Group
55/100
Stale StatementsGenerated Oct 31, 2026 · 10:00 AM UTC · 4 hours ago
This copy is frozen (Oct 31). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierCI
EquityThe Cigna Group · XNYS
Decision context
Recommendation
Balanced between solid Value (91/100) and constrained Quality (30/100).
A mixed picture — no strong reason to buy or sell right now.
AlphaDog Fair Value
Executive thesis & key metrics
Executive Thesis
Strong valuation (90.8/100), but base target implies 44.1% upside — P/E 12.3x.
Key Metrics to Watch
What changed recently
No material changes found in the last 30 days.
Why this rating
Score 55 · Hold
Data through
Stale StatementsJun 30, 2026
A newer quarter has been reported and is not in these statements.
Value 91/100 — P/E 12.3x screens cheap vs inputs.
Re-evaluate if
- Net margin falls below 1.8% (was 2.3%)
Trim / reconsider if
- ROA falls below 2.9% (was 4.5%)
Think of these dollars as a map of our value estimate for Hold — helpful context, not a reason to override the view.
A Calmer Look · Devil's Advocate
Both sides of the The Cigna Group story, next to the Hold above
Nothing stood out enough for a second opinion on this run.
Market context
Snapshot returns at report publication
1 month
+11.3%
3 months
+5.7%
6 months
+5.4%
1 year
-0.3%
At a Glance
A large company is on a steady trend at modest pricing.
Top Holders
As of Jun 30, 2026Financial trajectory
Financial Performance
Go deeper
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full CI dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.